Objectives: The pandemic of coronavirus disease 2019 (COVID-19) is still effective all over the world. Compared to adults, data on pediatric patients are limited. In this study, we aimed to retrospectively examine the demographic, clinical, and laboratory characteristics of pediatric patients who were followed up with the diagnosis of COVID-19 in the first 3 months of the pandemic in our hospital. Methods: A total of 190 patients, aged 1 month–18 years, who were followed up with a definite/probable diagnosis of COVID-19, who were treated in the Pediatric Infection Clinic, were included in the study. The demographic features, clinical characteristics, and laboratory findings of the patients were retrospectively analyzed from their electronic medical records. Results: Eighty (42.1%) of the patients were laboratory confirmed (Polymerase chain reaction positive in nasopharyngeal swab). Mean age was 72 (2–216 months) and 102 (53.7%) patients were female. Family contact history was present in 115 (60.5%) patients. The patients were classified as asymptomatic (5.8%), mild (73.2%), moderate (18.4%), and severe/critical (2.6%) according to the severity of the disease. The most common symptoms were cough (71.1%) and fever (51.1%). Hydroxychloroquine alone or in combination was the most commonly used agent. Conclusion: In our study, in which we examined the pediatric COVID-19 patients, most of the patients had a mild clinical course, but there were applications with different clinical pictures such as acute appendicitis. Therefore, COVID-19 infection, which is still very unknown, will continue to surprise us with both changing treatment protocols and clinical presentations such as multisystem inflammatory syndrome in children.
The Coronavirus disease 2019 (COVID-19) pandemic continues to be affected worldwide. Data on children’s patients is limited compared to adults. In this study, we aim to retrospective the demographic, clinical, laboratory characteristics of children patients followed by the diagnosis of COVID-19 in the first three months of pandemic in our hospital. Method: 190 patients between 1 month and 18 years of age, followed by COVID-19 diagnosis, were included in the study in the Infectious Clinic. Patients' demographic structures, clinical characteristics and laboratory findings were examined retrospectively from electronic medical records. Results: 80% of patients (42.1%) were confirmed in the laboratory (PCR positive in nasopharyngeal thyroid). The average age is 72 (2-216 months), 102 (53%). She was a sick girl. The family-internal contact history was present in 115 (60.5) patients. Patients were classified as asymptomatic (5.8 percent), light (73.2 percent), medium (18.4 percent) and heavy/critical (2.6 percent) according to the severity of the disease. The most common symptoms were coughing (71.1%) and fever (51.1%). Hydroxychloroquine was the most commonly used agent either single or combined. In our study we studied children’s age group COVID-19 patients, the majority of patients showed light clinical trajectory but were present in applications with different clinical tables such as acute appandicitis. Therefore, the COVID-19 infection, which is still very unknown, will continue to surprise us with clinical presentations such as MIS-C if it requires changing treatment protocols. (SETB-2021-06-197)
Field : Sağlık Bilimleri
Journal Type : Ulusal
Relevant Articles | Author | # |
---|
Article | Author | # |
---|